USPTO serial 85617490
ARESPAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ARESPAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Bevilacqua, Esquire
MICHAEL J BEVILACQUA WILMER CUTLER PICKERING HALE AND DORRIS LLP60 STATE STREETBOSTON, MA 02109UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | anti-allergic preparations; analgesics; anti-infectives; anti-inflammatories; pharmaceutical preparations and substances for the treatment of epilepsy, neuropathic pain, and bipolar disorder; anti-epileptic drugs; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases of the central nervous system, peripheral nervous system, respiratory system, urogenital system, cardiovascular system, endocrine system, metabolic system, renal system, gastroenterologic system, ophthalmologic system, and dermatologic system; pharmaceutical preparations and substances for the prevention and treatment of hematologic and oncologic disorders and diseases, psychiatric disorders and diseases, allergic disorders and diseases and disorders and diseases of the immune system, connective tissue and joints; and pharmaceutical preparations and substances for the prevention and treatment of insomnia and other sleep related diseases and disorders; pharmaceutical preparations for the prevention and treatment of cancer | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 21, 2013 | MAB4 | ABANDONMENT NOTICE MAILED - INTER PARTES DECISION | — |
| Jun 21, 2013 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Jun 21, 2013 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 21, 2013 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Feb 6, 2013 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 7, 2012 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 9, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 9, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 19, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 29, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 24, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 6, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 11, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 8, 2012 | NWAP | NEW APPLICATION ENTERED | — |